Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s share price traded up 2.3% on Friday . The company traded as high as €47.00 ($48.45) and last traded at €46.56 ($48.00). Approximately 224,325 shares changed hands during trading, an increase of 138% from the average session volume of 94,405 shares. The stock had previously closed at €45.52 ($46.93).
Carl Zeiss Meditec Trading Down 1.2 %
The firm has a fifty day moving average of €54.62 and a 200-day moving average of €60.46. The stock has a market capitalization of $4.12 billion, a price-to-earnings ratio of 20.18, a P/E/G ratio of 2.83 and a beta of 0.98. The company has a debt-to-equity ratio of 6.74, a quick ratio of 2.47 and a current ratio of 3.51.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- Comparing and Trading High PE Ratio Stocks
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- What Are Treasury Bonds?
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
